PRECISION
NEUROSCIENCE

Transformational therapies

OUR SCIENCE

Addressing the needs of patients with devastating and life-limiting disorders is central to our focus. Our scientific expertise in molecular mechanisms and the complex neurocircuitry underlying disorders of the nervous system is driving our development of new treatments.

ABOUT US

Engrail Therapeutics is a clinical-stage pharmaceutical company founded in 2019 with the aspiration of becoming a leader in neuroscience. We are committed to rapidly advancing our innovative, precision-targeted therapeutics.

Partners

Engrail’s innovative pipeline has been built through strong partnerships and internal discovery capabilities. This approach is central to achieving our mission.